Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01659125 · ClinicalTrials.gov registry record · NA

Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)

A NA study, sponsored by Hartford Hospital.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT01659125: Completed NA study, sponsored by Hartford Hospital.

NCT01659125 is a NA study that has completed, run by Hartford Hospital. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01659125, a NA study, has completed, sponsored by Hartford Hospital.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

The primary aim of this study is to learn about who is most likely to benefit from guided self-help (GSH) for obsessive-compulsive disorder (OCD).

Primary Outcome

The Y-BOCS is a semi-structured interview that assesses severity of obsessions and compulsions. The total score is reported here and ranges from 0 to 40 with higher scores indicating more severe OCD symptoms.

Interventions

  • BEHAVIORAL "OCFighter"

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2012-08
Est. Completion 2014-06
Phase NA
Hartford Hospital

75 total trials

What the finished NCT01659125 record still lists

NCT01659125 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which "OCFighter" is the first listed.

NCT01659125 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01659125 about?

NCT01659125 is a clinical study titled "Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)". The primary aim of this study is to learn about who is most likely to benefit from guided self-help (GSH) for obsessive-compulsive disorder (OCD).

What is the current status of trial NCT01659125?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2012-08. Estimated completion is 2014-06.

What interventions are being tested in trial NCT01659125?

The interventions under investigation include: "OCFighter" (BEHAVIORAL).

Who is sponsoring clinical trial NCT01659125?

This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01659125's enrollment target sits among peer trials

26 1710th of 2000 higher than 289 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01659125, the US trial registry maintained by the National Library of Medicine. NCT01659125 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.